🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In registry studies of CAR-T products that have been marketed globally, pat...
Status
Unknown
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2023-06-10
Trial ID
NCT05871684
Treatments Being Tested
This is a Phase 1/2, open-label, multicenter study to determine the efficac...
Status
Active Not Recruiting
Location
Local Institution - 0006
Start Date
2017-11-27
Trial ID
NCT03331198
This is a Phase 1/2 study of the combination of Ad-p53 administered intra-a...
Status
Terminated
Location
MD Anderson Cancer Center
Start Date
2018-11-20
Trial ID
NCT02842125
This is a Phase 1, first in human (FIH), Open-Label, Dose Escalation, Dose ...
Status
Recruiting
Location
Site-111
Start Date
2025-03-20
Trial ID
NCT06874335
Treatments Being Tested
The study is to evaluate the R0 resection rate of patients with unresectabl...
Status
Terminated
Location
Zhejiang procincial people's hospital
Start Date
2017-11-20
Trial ID
NCT03585062
Treatments Being Tested
This research study is evaluating the safety and efficacy of a combination ...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2020-07-20
Trial ID
NCT04290546
Treatments Being Tested
This study is a clinical trial to determine the safety of inoculating G207 ...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-09-12
Trial ID
NCT03911388
Treatments Being Tested
This is an open-label, multicenter, Phase II study to evaluate the efficacy...
Status
Active Not Recruiting
Location
Research Site
Start Date
2024-02-22
Trial ID
NCT06271837
Treatments Being Tested
This phase I/II trial investigates the side effects of genetically engineer...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2021-07-19
Trial ID
NCT04639245
The purpose of the study is to demonstrate clinical efficacy of the investi...
Status
Terminated
Location
Multiple Locations
Start Date
2007-03
Trial ID
NCT00452140
Treatments Being Tested